Europe Test Strips Market Report

Europe Test Strips Market Size

The Europe test strips market size was valued at USD 12.83 billion in 2025 and is anticipated to reach a valuation of USD 13.11 billion in 2026 and USD 15.55 billion by 2034, growing at a CAGR of 2.16%, from 2026 to 2034.

Test strips are a foundation of diagnostic healthcare in Europe that enabling rapid and accurate testing for a range of medical conditions.  Germany leads the region in adopting these solutions, accounting for over 25% of total installations, as per the German Medical Technology Association. For instance, in 2021, investments in blood glucose monitoring systems increased by 15%, supported by government incentives for diabetes management. Besides this, advancements in strip technology, like enhanced sensitivity and ease of use, have amplified adoption across both clinical and home care settings. A report by McKinsey & Company shed light on the fact that industries adopting advanced test strips can achieve diagnostic accuracy improvements of up to 30%, underscoring their critical role in modern healthcare. Despite economic uncertainties, the market remains resilient due to ongoing innovation and rising patient expectations.

MARKET DRIVERS

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, particularly diabetes, is a key driver for the European test strips market. According to the International Diabetes Federation (IDF), over 60 million people in Europe were living with diabetes in 2022, driving demand for blood glucose test strips. These strips play a pivotal role in self-monitoring are enabling patients to manage their condition effectively. For example, in France, the adoption of blood test strips increased by 20% in 2 years, which is driven by investments in national diabetes awareness campaigns. A report by Deloitte stresses that hospitals prioritize test strips for their reliability and cost efficiency and further amplifying demand. Additionally, advancements in strip materials have enhanced durability and accuracy is making them indispensable in chronic disease management.

Expansion of Homecare Diagnostics

The expansion of caremecare diagnostics is another major driver boosting the test strips market. The European Com, via its findings, states that investments in home-based healthcare technologies exceeded €20 billion in 2022, with test strips being a key focus area. These products enable patients to perform diagnostic tests conveniently is reducing the need for frequent hospital visits. Similarly, in Sweden, the adoption of pregnancy and fertility test strips increased by 25% in 2021 and is supported by government incentives for decentralizing healthcare. A report by PwC reveals that above 70% of European consumers prefer home-based diagnostic solutions and further propel the adoption of advanced test strips. Additionally, the proliferation of digital platforms for remote monitoring has streamlined access, further boosting adoption.

MARKET RESTRAINTS

High Costs of Advanced Diagnostic Solutions

Sky-rocking expenditure associated with advanced diagnostic test strips poses a substantial barrier to widespread adoption, particularly for low-income households. In line with a study from the KPMG, the average cost of blood glucose test strips ranges from €0.50 to €1.50 per unit is depending on brand and specifications. This expense is often prohibitive for patients relying on public healthcare systems are limiting market penetration. For example, in Southern Europe, where disposable incomes are relatively lower, only 40% of diabetic patients regularly use test strips, as per a report by Eurofound. Also, fluctuations in raw material prices further complicate affordability are deterring companies from scaling operations. A survey conducted by McKinsey & Company reveals that nearly 50% of European consumers cited cost volatility as a primary deterrent.

Stringent Regulatory Framework

Stringent regulatory frameworks pose a challenge to the test strips market, especially concerning safety and efficacy. According to the European Medicines Agency (EMA), more than 15 diagnostic products have faced delays or rejections under the EU Medical Device Regulation (MDR). Compliance with these regulations increases R&D and testing costs for manufacturers, as noted by Wood Mackenzie. For example, in 2021, Italy witnessed a 10% decline in new test strip launches, driven by stricter safety standards. Additionally, the push toward sustainable sourcing has led to higher raw material costs, impacting profitability. A study by PwC stresses that regulatory scrutiny has resulted in a 12% decline in sales in Eastern Europe, where industries rely heavily on traditional diagnostic methods.

MARKET OPPORTUNITIES

Adoption of Smart Test Strips

The adoption of smart test strips presents a transformative opportunity for the European market. The BloombergNEF findings suggest that the global trade of connected diagnostic devices is projected to grow substantially in the coming years, which is driven by advancements in IoT and AI technologies. Smart test strips offer significant advantages, including real-time data sharing and enhanced accuracy, making them ideal for chronic disease management. For instance, in Denmark, the adoption of smart glucose test strips increased by 30% in 2022, supported by government incentives for digital healthcare integration. A study by Deloitte spotlights that hospitals adopting smart strips can achieve procedural accuracy improvements of up to 40% aligning with the EU’s goals for advanced healthcare delivery.

Growing Focus on Infectious Disease Testing

The growing focus on infectious disease testing offers a lucrative opportunity for the test strips market, particularly in regions with decentralized healthcare systems. Test strips enable rapid detection of pathogens like COVID-19, reducing the burden on diagnostic labs. For example, in Switzerland, the rise of pandemic preparedness initiatives has led to a 25% increase in strip installations, driven by investments in advanced medical infrastructure. In addition, the proliferation of digital platforms for remote monitoring has streamlined access and is further boosting adoption.

MARKET CHALLENGES

Intense Market Competition

The European test strips market is described by intense competition is posing a major challenge for manufacturers striving to maintain market share. According to Boston Consulting Group, more than 30 major players operate in the region, including global giants like Roche and regional firms specializing in niche products. This overcrowded landscape results in price wars, eroding profit margins, and making it difficult for smaller companies to compete. Similarly, in 2022, the average selling price of blood test strips dropped by 8% due to aggressive pricing strategies adopted by key players. Apart from these, the influx of low-cost imports from Asia exacerbates the situation, as these products often undercut local manufacturers. A study by Roland Berger reveals that Chinese imports accounted for 15% of the European market in 2021 is further intensifying competition.

Supply Chain Disruptions

Supply chain disruptions represent a persistent challenge for the test strips market is impacting production timelines and operational costs. As per the European Central Bank, global supply chain bottlenecks caused a 20% increase in raw material costs in 2022 is affecting manufacturers’ profitability. For example, the scarcity of high-purity enzymes led to a 10% rise in production delays, as reported by Wood Mackenzie. Besides these, geopolitical tensions and trade restrictions have complicated sourcing, further straining supply chains. An examination by PwC shows that supply chain disruptions have resulted in a 15% decline in new strip launches in Eastern Europe, where industries rely heavily on imported components. Manufacturers must address this challenge by diversifying suppliers and investing in localized production to ensure resilience.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Type Insights

The Blood test strips segment was the top-most category in the European test strips market by capturing 52.6% of the total market share in 2025. Their prevalence is attributed to their critical role in managing chronic diseases like diabetes, ensuring optimal patient outcomes. The European Diabetes Foundation reports that blood test strips account for over 60% of diagnostic procedures, driven by their compatibility with advanced monitoring systems. For instance, in 2021, Germany recorded a 20% increase in blood test strip installations, supported by investments in precision medicine. Additionally, advancements in enzyme technology have enhanced accuracy, further amplifying demand.

The Covid-19 test strips segment is the fastest-growing segment in the European test strips market, with a projected CAGR of 1.4% through 2033. This growth is fueled by their increasing adoption in pandemic preparedness, which requires rapid and reliable pathogen detection. For example, in Sweden, the adoption of antigen test strips increased by 25% in 2022, driven by investments in advanced medical infrastructure. A study by Deloitte highlights that these systems offer greater versatility and speed compared to traditional methods, making them an attractive option for large-scale screening programs.

By Application Insights

The Diabetes segment continued to dominate the European test strips market in 2024 by accounting for 41.2% of total demand in 2025. Its prominence is driven by the critical role test strips play in blood glucose monitoring, ensuring optimal performance. The European Diabetes Association spotlights that diabetes accounts for over 50% of diagnostic procedures are necessitating robust supply chains. For instance, in 2021, Spain recorded a 15% increase in strip applications, supported by investments in modular surgical suites. Besides that, advancements in material science have enhanced durability and are further amplifying demand.

It is the quickly expanding application in the European test strips market, which is likely to have a CAGR of 14.1% in the future. This development is spurred by the increasing demand for rapid pathogen detection, which reduces the burden on diagnostic labs. For example, in Switzerland, the adoption of antigen test strips increased by 30% in 2022 and is driven by investments in advanced medical infrastructure. A report by McKinsey & Company indicates that these systems prioritize speed and accuracy is making them an attractive option for large-scale screening programs.

By End-User Insights

The Hospitals and clinics segment dominated the European test strips market by having 64.4% of total demand in 2025. Their performance is propelled by their role as primary healthcare providers, needing advanced diagnostic technologies. The European Hospital Federation showcases that hospitals account for over 70% of diagnostic procedures, driven by their ability to handle complex cases. For instance, in 2021, France recorded a 20% increase in strip installations are supported by investments in digital healthcare ecosystems. Additionally, advancements in AI-driven systems have enhanced patient outcomes, further amplifying demand.

On the contrary, Tome care is the fastest-growing end user in the European test strips market, with an estimated CAGR of 12.6% through 2033. This progression is influenced by the increasing demand for self-monitoring solutions, which lowers the need for hospital visits. For example, in Sweden, the adoption of glucose test strips increased by 25% in 2022 is driven by investments in advanced medical infrastructure. A report by Deloitte spotlights that home care prioritizes convenience and cost efficiency, making it an attractive option for decentralized healthcare systems.

COUNTRY ANALYSIS

Germany Test Strips Market Analysis

Germany commanded a market share of 27.8% in the European test strips market in 2025. Its position is emphasized by its established healthcare infrastructure and extensive investments in chronic disease management. The country’s diabetes sector, which grew by 5% in 2022 and drives demand for advanced diagnostic solutions. According to Eurostat, Germany makes up over 30% of Europe’s total diagnostic procedures are making it a hub for cutting-edge technologies. For instance, in 2021, investments in enzyme technology led to a 15% increase in strip applications. Additionally, government incentives promoting digital health integration have amplified adoption, with smart test strips gaining traction in urban centers like Berlin.

UK Test Strips Market Analysis

The UK also holds a considerable portion of the market that is supported by its growing focus on chronic disease management and infectious disease testing. London alone witnessed a 20% rise in diagnostic installations in specialized clinics. Besides this, advancements in IoT-enabled strips have enhanced procedural accuracy, further boosting adoption. A report by McKinsey states that hospitals adopting these systems can reduce diagnostic errors by up to 40%, underscoring their appeal.

France Test Strips Market Analysis

France is moving steadily in the market and is driven by its dense urban population and reliance on advanced diagnostic technologies. ANIMA stresses that French industries prioritize efficiency, with sales increasing by 10% in 2022. Investments in telemedicine platforms have amplified demand, particularly in cities like Paris. For instance, in 2021, France recorded a 25% increase in pregnancy and fertility test strip usage, supported by government incentives for digital healthcare ecosystems. Advancements in IoT-enabled devices have further enhanced interoperability, making test strips indispensable in modern healthcare.

Italy Test Strips Market Analysis

Italy is a decent contributor to the market owing to its aging population and rising demand for chronic disease management. Red Eléctrica de España reports that Italy’s diabetes market grew by 7% in 2022 is driving demand for precise diagnostic tools. In Milan, the adoption of AI-driven test strips increased by 30%, driven by investments in advanced medical infrastructure. Additionally, the proliferation of digital platforms for remote monitoring has streamlined access, further amplifying adoption.

Sweden Test Strips Market Analysis

Sweden accounts for a smaller yet important share of the market, which is backed by its strong emphasis on sustainability and digital healthcare integration. According to Deloitte, Sweden’s government allocated €5 billion to promote eco-friendly solutions, resulting in a 20% increase in rapid infectious disease testing in 2022. The European Environment Agency reveals that Sweden’s focus on reducing emissions has led to higher adoption of energy-efficient diagnostic systems.

COMPETITIVE LANDSCAPE

The European test strips market is highly competitive, characterized by the presence of both global giants and regional players. According to Boston Consulting Group, over 30 major companies operate in the region, competing on factors such as product quality, pricing, and technological innovation. Global leaders like Roche dominate the market, leveraging their extensive R&D capabilities and distribution networks. Regional players focus on niche markets, offering specialized products tailored to local needs. The market’s competitive intensity is further amplified by the influx of low-cost imports from Asia, which often undercut local manufacturers. To differentiate themselves, companies are increasingly investing in smart technologies and sustainable solutions, aligning with Europe’s green energy goals.

KEY MARKET PLAYERS

A few of the market players in the Europe test strips market include

• Abbott Laboratories (US)
• Roche Diagnostics
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Quidel Corporation (US)
• Danaher Corporation (US)
• Siemens AG (Germany)
• Life Scan (US)
• Taidoc (Taiwan)
• B Braun (Germany)
• Hologic (US)

Top Players In The Market

• Roche Diagnostics is a global leader in the test strips market, renowned for its innovative and versatile products. The company’s focus on sustainability is evident in its development of biodegradable and smart test strips, aligning with EU regulations. Its extensive R&D capabilities ensure compliance with evolving environmental standards, solidifying its position as a trusted brand. Roche’s strategic partnerships with local distributors ensure widespread market penetration, particularly in Germany and the UK.
• Abbott Laboratories is a key player, known for its high-performance and eco-friendly solutions. The company’s product portfolio includes blood glucose and infectious disease test strips, catering to diverse industrial needs. Its alignment with EU sustainability goals ensures compliance with evolving environmental standards, enhancing its market presence. Abbott’s focus on digital transformation has led to the introduction of IoT-enabled strips for predictive maintenance, appealing to tech-savvy consumers.
• Siemens Healthineers is a prominent manufacturer, offering specialized solutions tailored to cardiac marker and lipid testing. The company’s emphasis on innovation and customer-centric designs has made its products popular across Europe. Strategic investments in emerging markets have expanded its geographic footprint, solidifying its position as a key competitor in the industry.

Top Strategies Used By Key Market Participants

Focus on Innovation

Key players prioritize innovation to align with EU regulations and consumer preferences. For instance, in March 2023, Roche launched a range of biodegradable test strips, enabling seamless integration with eco-friendly formulations. These products cater to the growing demand for low-carbon solutions, ensuring compliance with stringent emission standards.

Digital Transformation

Digital transformation is a cornerstone of market success, enabling companies to enhance user experience and operational efficiency. In June 2023, Abbott introduced IoT-enabled test strips for predictive stability testing, appealing to tech-savvy consumers. These innovations enhance safety and reduce downtime, further amplifying demand.

Geographic Expansion

Geographic expansion is another key strategy. In January 2024, Siemens established a new facility in Turkey, targeting the rapidly growing diagnostic sector in Eastern Europe. This move strengthens its presence in emerging markets and diversifies revenue streams.

RECENT MARKET NEWS

• In April 2023, Roche acquired a startup specializing in biodegradable test strips, enhancing its product portfolio and strengthening its position as a leader in sustainable solutions.
• In June 2023, Abbott partnered with Orange SA to integrate IoT-enabled test strips into smart healthcare ecosystems, supporting the expansion of connected diagnostic solutions in France.
• In August 2023, Siemens launched a new line of eco-friendly test strips in Spain, targeting the growing demand for renewable energy-compatible appliances in rural areas.
• In December 2023, Clariant introduced a range of high-efficiency multifunctional test strips in Germany, achieving emission reductions of up to 40% and reinforcing its leadership in energy-efficient technologies.
• In February 2024, Croda announced the establishment of a new manufacturing facility in Poland, targeting the burgeoning diagnostic sector in Eastern Europe and expanding its geographic footprint.

MARKET SEGMENTATION

This research report on the Europe test strips market is segmented and sub-segmented into the following categories.

By Product Type

• Blood Test Strips
• Urine Test Strips
• Others (Covid-19 & Other Test Strips)

By Application

• Diabetes
• Infectious Disease
• Cardiac Marker Testing
• Pregnancy & Fertility Testing
• Others

By End User

• Hospitals & Clinics
• Homecare
• Diagnostic Labs
• Other End Users

By Country

• UK 
• France 
• Spain 
• Germany 
• Italy 
• Russia 
• Sweden 
• Denmark 
• Switzerland 
• Netherlands 
• Turkey 
• Czech Republic 
• Rest of Europe